A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

4 Citeringar (SciVal)

Sammanfattning

Is the oncogene MYC upregulated or hyperactive? In the majority of human cancers, finding agents that target c-MYC has proved difficult. Here we report specific bacterial effector molecules that inhibit cellular MYC (c-MYC) in human cells. We show that uropathogenic Escherichia coli (UPEC) degrade the c-MYC protein and attenuate MYC expression in both human cells and animal tissues. c-MYC protein was rapidly degraded by both cell-free bacterial lysates and the purified bacterial protease Lon. In mice, intravesical or peroral delivery of Lon protease delayed tumor progression and increased survival in MYC-dependent bladder and colon cancer models, respectively. These results suggest that bacteria have evolved strategies to control c-MYC tissue levels in the host and that the Lon protease shows promise for therapeutic targeting of c-MYC in cancer.

Originalspråkengelska
Sidor (från-till)754–764
Antal sidor11
TidskriftNature Biotechnology
Volym39
Utgåva6
Tidigt onlinedatum2021 feb 11
DOI
StatusPublished - 2021 jun 1

Ämnesklassifikation (UKÄ)

  • Mikrobiologi inom det medicinska området

Fingeravtryck

Utforska forskningsämnen för ”A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här